| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | A New Drug Design Targeting the Adenosinergic System for Huntington's Disease | Huang, N-K; Lin, J-H; Lin, J-T; Lin, C-I; Liu, E, M; Lin, C-J; Chen, W-P; Shen, Y-C; Chen, H-M; Chen, J-B; Lai, H-L; Yang, C-W; Chiang, C-M; Wu, Y-S; Chang, C; Chen, J-F; Fang, J-Mx; Lin, Y-Lx; Chern, Y | PLoS ONE 6, e20934 | | | |
| 2015 | Aberrant astrocytes impair vascular reactivity in Huntington disease | Hsiao, H-Y; Chen, Y-C; Huang, C-H; Chen, C-C; Hsu, Y-H; Chen, H-M; Chiu, F-L; Kuo, H-C; Chang, C; Chern, Y | Annals of Neurology 78(2), 178-192 | | | |
| 2007 | Bioinformatic prediction and experimental validation of a microRNA-directed tandem trans-acting siRNA cascade in Arabidopsis. | Chen, H-M; Li, Y-H; Wu, S-H | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 104(9), 3318-3323 | | | |
| 2011 | Dysregulated brain-type creatine kinase contributes to hearing impairment in mice with Huntington’s disease. | Lin, Y-S; Chen, C-M; Soong, B-w; Wu, Y-R; Chen, H-M; Wu, D-R; Lin, Y-C; Wang, C-Hx; Chern, Y | Journal of Clinical Investigation 121, 1519-1523 | | | |
| 2010 | Modulation of energy deficiency in Huntington’s disease via activation of the peroxisome proliferator-activated receptor gamma. | Chiang, M-C; Chen, C-M; Lee, M-R; Chen, H-W; Chen, H-M; Wu, Y-S; Hung, C-H; Kang, J-J; chang, C-P; Chang, C; Wu, Y-R; Tsai, Y-S; Chern, Y | Human Molecular Genetics 19, 4043-4058 | | | |
| 2009 | The A2A adenosine receptor rescues the urea cycle deficiency of Huntington’s disease by enhancing the activity of the ubiquitin-proteasome system | Chiang, M-C; Chen, H-M; Lai, H-L; Chen, H-W; Chou, S-Y; Chen, C-M; Tsai, F-J; Chern, Y | Human Molecular Genetics 18(16), 2929-2942 | | | |
